회사 소개
- 법인명: ARCALIS, Inc.
- 등록 국가: Japan
- 주소: 226-39, Wakashiba,,, Kashiwa Shi
- 직원 수: 100 - 249
설명:
A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.
사업 활동
ATC 분류체계 (해부치료화학분류)
위탁제조업체 (CMO)
당사 제품 & 서비스
인증
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기